CUSIP 30049G203
EVOKE PHARMA INC
27 institutions · $1.5M total · 2,890,607 shares
| # | Manager | Shares | Value | % of Total | Period |
|---|---|---|---|---|---|
| 1 | Bleichroeder LP | 825,000 | $436.4K | 28.54% | 2024-06-30 |
| 2 | Altium Capital Management LP | 692,440 | $366.3K | 23.95% | 2024-06-30 |
| 3 | Nantahala Capital Management, LLC | 675,000 | $357.1K | 23.35% | 2024-06-30 |
| 4 | AIGH Capital Management LLC | 550,365 | $291.1K | 19.03% | 2024-06-30 |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 48,844 | $25.8K | 1.68% | 2024-06-30 |
| 6 | VANGUARD GROUP INC | 29,851 | $15.8K | 1.03% | 2024-06-30 |
| 7 | GOLDMAN SACHS GROUP INC | 13,471 | $8.2K | 0.46% | 2024-03-31 |
| 8 | MILLENNIUM MANAGEMENT LLC | 10,869 | $6.6K | 0.37% | 2024-03-31 |
| 9 | CITADEL ADVISORS LLC | 11,911 | $6.3K | 0.41% | 2024-06-30 |
| 10 | STATE STREET CORP | 10,660 | $5.6K | 0.36% | 2024-06-30 |
| 11 | Tower Research Capital LLC (TRC) | 7,479 | $4.0K | 0.25% | 2024-06-30 |
| 12 | BlackRock Inc. | 1,464 | $774 | 0.05% | 2024-06-30 |
| 13 | UBS Group AG | 1,107 | $586 | 0.03% | 2024-06-30 |
| 14 | MORGAN STANLEY | 375 | $198 | 0.01% | 2025-03-31 |
| 15 | Lindbrook Capital, LLC | 83 | $158 | 0.00% | 2023-06-30 |
| 16 | NewEdge Advisors, LLC | 208 | $110 | 0.00% | 2024-06-30 |
| 17 | PNC Financial Services Group, Inc. | 16 | $43 | 0.00% | 2023-03-31 |
| 18 | Concord Wealth Partners | 31 | $43 | 0.00% | 2024-03-31 |
| 19 | WELLS FARGO & COMPANY/MN | 66 | $40 | 0.00% | 2024-03-31 |
| 20 | FMR LLC | 71 | $38 | 0.00% | 2024-06-30 |
| 21 | BANK OF AMERICA CORP /DE/ | 69 | $37 | 0.00% | 2024-06-30 |
| 22 | RENAISSANCE TECHNOLOGIES LLC | 11,178 | $21 | 0.38% | 2023-06-30 |
| 23 | Federation des caisses Desjardins du Quebec | 5 | $16 | 0.00% | 2024-06-30 |
| 24 | HARBOR INVESTMENT ADVISORY, LLC | 0 | $0 | 0.00% | 2023-03-31 |
| 25 | CWM, LLC | 16 | $0 | 0.00% | 2023-12-31 |
| 26 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% | 2024-06-30 |
| 27 | Royal Bank of Canada | 28 | $0 | 0.00% | 2024-09-30 |